Skip to Main Content
TABLE 2

Presentation of Patients Hospitalized for COVID-19, by Age Group, 6 Hospitals, United States, July to August 2021, N = 759

<1 Years
(n = 176)
1–4 Years
(n = 122)
5–11 Years
(n = 143)
12–17 Years
(n = 272)
18–20 Years
(n = 46)
Presenting sign or symptom,an (%)      
 Constitutional 176 (100) 122 (100) 143 (100) 270 (99.3) 46 (100) 
  Objective fever 120 (68.2) 88 (72.1) 101 (70.6) 165 (60.7) 29 (63.0) 
 Poor appetite 77 (43.8) 63 (51.6) 68 (47.6) 118 (43.4) 19 (41.3) 
 Lower respiratory 119 (67.6) 91 (74.6) 100 (69.9) 237 (87.1) 38 (82.6) 
 Cough 103 (58.5) 86 (70.5) 91 (63.6) 196 (72.1) 31 (67.4) 
  SOB or dyspnea 70 (39.8) 49 (40.2) 54 (37.8) 188 (69.1) 28 (60.9) 
 Upper respiratory 123 (69.9) 79 (64.8) 84 (58.7) 137 (50.4) 21 (45.7) 
  Sore throat 2 (1.1) 7 (5.7) 36 (25.2) 59 (21.7) 10 (21.7) 
  Rhinorrhea or nasal congestion 120 (68.2) 77 (63.1) 69 (48.3) 114 (41.9) 16 (34.8) 
 Neurologic 8 (4.5) 19 (15.6) 49 (34.3) 122 (44.9) 15 (32.6) 
  Headache 0 (0) 3 (2.5) 40 (28.0) 89 (32.7) 13 (28.3) 
 Gastrointestinal 57 (32.4) 62 (50.8) 88 (61.5) 166 (61.0) 26 (56.5) 
  Nausea or vomiting 47 (26.7) 44 (36.1) 69 (48.3) 136 (50.0) 20 (43.5) 
  Diarrhea 29 (16.5) 37 (30.3) 36 (25.2) 72 (26.5) 15 (32.6) 
 Rash 11 (6.3) 7 (5.7) 8 (5.6) 4 (1.5) 1 (2.2) 
Admission diagnosis,bn (%)      
 COVID-19 131 (74.4) 86 (70.5) 103 (72.0) 216 (79.4) 38 (82.6) 
 Pneumonia 12 (6.8) 32 (26.2) 40 (28.0) 97 (35.7) 16 (34.8) 
 COVID-19 pneumonia 8 (4.5) 27 (22.1) 35 (24.5) 90 (33.1) 16 (34.8) 
 Bronchiolitis 37 (21.0) 16 (13.1) 1 (0.7) 0 (0) 0 (0) 
 RSV 26 (14.8) 14 (11.5) 3 (2.1) 1 (0.4) 0 (0) 
Initial vitals,cn (%)      
 Febrile temperature 58 (33.0) 37 (30.3) 25 (17.5) 70 (25.7) 15 (32.6) 
 Tachycardic 29 (16.5) 42 (34.4) 55 (38.5) 128 (47.1) 28 (60.9) 
 Tachypneic 36 (20.5) 31 (25.4) 92 (64.3) 176 (64.7) 25 (54.3) 
Chest radiograph performed, n (%) 103 (58.5) 90 (73.8) 106 (74.1) 232 (85.3) 42 (91.3) 
 Any abnormality 78 (75.7) 66 (73.3) 84 (79.2) 196 (84.5) 33 (78.6) 
 Infiltrate or consolidation 36 (35.0) 38 (42.2) 52 (49.1) 147 (63.4) 26 (61.9) 
Coinfections, n (%)      
 Viral 57 (32.4) 44 (36.1) 6 (4.2) 6 (2.2) 0 (0) 
  RSV 42 (23.9) 26 (21.3) 4 (2.8) 3 (1.1) 0 (0) 
  Otherd 22 (12.5) 23 (18.9) 3 (2.1) 3 (1.1) 0 (0) 
 Bacteriale 23 (13.1) 27 (22.1) 30 (21.0) 43 (15.8) 14 (30.4) 
 Fungal 0 (0) 1 (0.8) 1 (0.7) 5 (1.8) 1 (2.2) 
<1 Years
(n = 176)
1–4 Years
(n = 122)
5–11 Years
(n = 143)
12–17 Years
(n = 272)
18–20 Years
(n = 46)
Presenting sign or symptom,an (%)      
 Constitutional 176 (100) 122 (100) 143 (100) 270 (99.3) 46 (100) 
  Objective fever 120 (68.2) 88 (72.1) 101 (70.6) 165 (60.7) 29 (63.0) 
 Poor appetite 77 (43.8) 63 (51.6) 68 (47.6) 118 (43.4) 19 (41.3) 
 Lower respiratory 119 (67.6) 91 (74.6) 100 (69.9) 237 (87.1) 38 (82.6) 
 Cough 103 (58.5) 86 (70.5) 91 (63.6) 196 (72.1) 31 (67.4) 
  SOB or dyspnea 70 (39.8) 49 (40.2) 54 (37.8) 188 (69.1) 28 (60.9) 
 Upper respiratory 123 (69.9) 79 (64.8) 84 (58.7) 137 (50.4) 21 (45.7) 
  Sore throat 2 (1.1) 7 (5.7) 36 (25.2) 59 (21.7) 10 (21.7) 
  Rhinorrhea or nasal congestion 120 (68.2) 77 (63.1) 69 (48.3) 114 (41.9) 16 (34.8) 
 Neurologic 8 (4.5) 19 (15.6) 49 (34.3) 122 (44.9) 15 (32.6) 
  Headache 0 (0) 3 (2.5) 40 (28.0) 89 (32.7) 13 (28.3) 
 Gastrointestinal 57 (32.4) 62 (50.8) 88 (61.5) 166 (61.0) 26 (56.5) 
  Nausea or vomiting 47 (26.7) 44 (36.1) 69 (48.3) 136 (50.0) 20 (43.5) 
  Diarrhea 29 (16.5) 37 (30.3) 36 (25.2) 72 (26.5) 15 (32.6) 
 Rash 11 (6.3) 7 (5.7) 8 (5.6) 4 (1.5) 1 (2.2) 
Admission diagnosis,bn (%)      
 COVID-19 131 (74.4) 86 (70.5) 103 (72.0) 216 (79.4) 38 (82.6) 
 Pneumonia 12 (6.8) 32 (26.2) 40 (28.0) 97 (35.7) 16 (34.8) 
 COVID-19 pneumonia 8 (4.5) 27 (22.1) 35 (24.5) 90 (33.1) 16 (34.8) 
 Bronchiolitis 37 (21.0) 16 (13.1) 1 (0.7) 0 (0) 0 (0) 
 RSV 26 (14.8) 14 (11.5) 3 (2.1) 1 (0.4) 0 (0) 
Initial vitals,cn (%)      
 Febrile temperature 58 (33.0) 37 (30.3) 25 (17.5) 70 (25.7) 15 (32.6) 
 Tachycardic 29 (16.5) 42 (34.4) 55 (38.5) 128 (47.1) 28 (60.9) 
 Tachypneic 36 (20.5) 31 (25.4) 92 (64.3) 176 (64.7) 25 (54.3) 
Chest radiograph performed, n (%) 103 (58.5) 90 (73.8) 106 (74.1) 232 (85.3) 42 (91.3) 
 Any abnormality 78 (75.7) 66 (73.3) 84 (79.2) 196 (84.5) 33 (78.6) 
 Infiltrate or consolidation 36 (35.0) 38 (42.2) 52 (49.1) 147 (63.4) 26 (61.9) 
Coinfections, n (%)      
 Viral 57 (32.4) 44 (36.1) 6 (4.2) 6 (2.2) 0 (0) 
  RSV 42 (23.9) 26 (21.3) 4 (2.8) 3 (1.1) 0 (0) 
  Otherd 22 (12.5) 23 (18.9) 3 (2.1) 3 (1.1) 0 (0) 
 Bacteriale 23 (13.1) 27 (22.1) 30 (21.0) 43 (15.8) 14 (30.4) 
 Fungal 0 (0) 1 (0.8) 1 (0.7) 5 (1.8) 1 (2.2) 

SOB, shortness of breath.

a As documented in the history of present illness. Constitutional: objective fever (body temperature ≥38°C), poor appetite, dehydration, chills, fatigue, lethargy, arthralgia or myalgia, and subjective fever; lower respiratory: cough and SOB or dyspnea; upper respiratory: sore throat, rhinorrhea or nasal congestion, and conjunctivitis; neurologic: headache, altered mental status, and seizures; gastrointestinal: nausea or vomiting, abdominal pain, and diarrhea.

b List is not exhaustive but includes the top 3 diagnoses for each age category.

c Febrile temperature is defined as body temperature ≥38°C for all ages. Tachycardia and tachypnea abnormal ranges are age-normalized.

d Included adenovirus, human coronavirus 229E, human coronavirus HKU1, human coronavirus NL63, human coronavirus OC43, human metapneumovirus, influenza virus, parainfluenza virus, and rhinovirus or enterovirus.

e Out of 137 patients, 23 (16.8%) had a positive bacterial culture. Bacteria isolated included Enterococcus sp, Escherichia coli, Facklamia hominis, Micrococcus sp, Propionibacterium acnes, Pseudomonas aeruginosa, Salmonella enterica, Staphylococcus aureus, Staphylococcus capitis, Staphylococcus epidermidis, Streptococcus (group B), Streptococcus intermedius, and Streptococcus pneumoniae.

Close Modal

or Create an Account

Close Modal
Close Modal